After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This AMEX-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of iBio Inc is $63.30M. A total of 2.2 million shares were traded on the day, compared to an average of 344.45K shares.
In the most recent transaction, Duran Felipe bought 9,191 shares of IBIO for 2.72 per share on Jan 10 ’25. After the transaction, the Chief Financial Officer now owns 11,139 company shares. In a previous transaction on Jan 10 ’25, Brenner Martin bought 9,191 shares at 2.72 per share. IBIO shares that the insider owns now total 18,316.
Among the insiders who bought shares, Banjak Marc acquired of 9,191 shares on Jan 10 ’25 at a per-share price of $2.72. This resulted in the Chief Legal Officer holding 11,066 shares of IBIO after the transaction. In another insider transaction, Arkowitz David bought 18,382 shares at $2.72 per share on Jan 10 ’25. Company shares held by the Director now total 18,382.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for IBIO in the last 3 months, the mean price target is $4.80 with high estimates of $6.00 and low estimates of $3.60. In terms of 52-week highs and lows, IBIO has a high of $5.83 and a low of $1.05.
As of this writing, IBIO has an earnings estimate of -$0.32 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.25 per share and a lower estimate of -$0.39.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IBIO’s latest balance sheet shows that the firm has $33.52M in Cash & Short Term Investments as of fiscal 2022. There were $25.77M in debt and $30.44M in liabilities at the time. Its Book Value Per Share was $1.52, while its Total Shareholder’s Equity was $63.48M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IBIO is Buy with a score of 5.00.
